Building on bioinformatic evidence suggesting miR-664b-3p as a potential target of circ-MBOAT2, the goal of this study is to elucidate the clinical significance of circ-MBOAT2 in NSCLC and to unravel its molecular mechanisms mediated by miR-664b-3p regulation. Here, MBOAT2 is linked to non-small cell lung carcinoma.